Cargando…

Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia

Almost two decades ago, the sequencing of the human genome and high throughput technologies came to revolutionize the clinical and therapeutic approaches of patients with complex human diseases. In acute lymphoblastic leukemia (ALL), the most frequent childhood malignancy, these technologies have en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bárcenas-López, Diego Alberto, Mendiola-Soto, Diana Karen, Núñez-Enríquez, Juan Carlos, Mejía-Aranguré, Juan Manuel, Hidalgo-Miranda, Alfredo, Jiménez-Morales, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Review article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720095/ https://www.ncbi.nlm.nih.gov/pubmed/33290991 http://dx.doi.org/10.1016/j.tranon.2020.100978

Ejemplares similares

MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia
por: Mendiola-Soto, Diana Karen, et al.
Publicado: (2023)

Long Non-Coding RNA and Acute Leukemia
por: Cruz-Miranda, Gabriela Marisol, et al.
Publicado: (2019)

Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
por: Mejía-Aranguré, Eréndira, et al.
Publicado: (2022)

Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
por: Jiménez-Morales, Silvia, et al.
Publicado: (2021)

Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia
por: Bárcenas-López, Diego Alberto, et al.
Publicado: (2020)

Underexpression of LINC00173 in TCF3/PBX1-Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia
por: May-Hau, Didier Ismael, et al.
Publicado: (2022)

Acute Leukemia in Children
por: Mejía-Aranguré, Juan Manuel, et al.
Publicado: (2015)

Prevalence of Gene Rearrangements in Mexican Children with Acute Lymphoblastic Leukemia: A Population Study—Report from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia
por: Bekker-Méndez, Vilma Carolina, et al.
Publicado: (2014)

EBV, HCMV, HHV6, and HHV7 Screening in Bone Marrow Samples from Children with Acute Lymphoblastic Leukemia
por: Morales-Sánchez, A., et al.
Publicado: (2014)

Editorial: Prevention in Acute Leukemias in Children
por: Mejia-Arangure, Juan M., et al.
Publicado: (2021)

Identification and Characterization of Novel Fusion Genes with Potential Clinical Applications in Mexican Children with Acute Lymphoblastic Leukemia
por: Mata-Rocha, Minerva, et al.
Publicado: (2019)

Towards personalized chemotherapy of acute lymphoblastic leukemia
por: Hnízda, Aleš, et al.
Publicado: (2018)

Management of adverse effects of new monoclonal antibody treatments in acute lymphoblastic leukemia
por: Conde-Royo, Diego, et al.
Publicado: (2020)

Overweight and obesity as predictors of early mortality in Mexican children with acute lymphoblastic leukemia: a multicenter cohort study
por: Núñez-Enríquez, Juan Carlos, et al.
Publicado: (2019)

Functional characterization of NK cells in Mexican pediatric patients with acute lymphoblastic leukemia: Report from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia
por: Valenzuela-Vazquez, Lucero, et al.
Publicado: (2020)

Analysis of RAS gene mutations in adverse events during first induction chemotherapy in childhood acute lymphoblastic leukemia
por: Chen, Tianping, et al.
Publicado: (2023)

NK cells with decreased expression of multiple activating receptors is a dominant phenotype in pediatric patients with acute lymphoblastic leukemia
por: Valenzuela-Vázquez, Lucero, et al.
Publicado: (2022)

DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia
por: Sexauer, Amy N., et al.
Publicado: (2023)

Reply: Comment on ‘Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican Inter-Institutional Group for the Identification of the Causes of Childhood Leukaemia (MIGICCL)' – A reality or myth or two viewpoints about the association between allergies and acute leukaemia in Down syndrome children
por: Núñez-Enríquez, J C, et al.
Publicado: (2013)

Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico
por: Vázquez-Cornejo, Edmundo, et al.
Publicado: (2022)

Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country
por: Barbosa-Cortés, Lourdes, et al.
Publicado: (2017)

The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment
por: Rudin, Shoshana, et al.
Publicado: (2017)

BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy
por: Slone, William L., et al.
Publicado: (2016)

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
por: Karol, Seth E., et al.
Publicado: (2021)

Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
por: Śliwa-Tytko, Patrycja, et al.
Publicado: (2022)

Chemotherapy-Induced Oxidative Stress in Pediatric Acute Lymphoblastic Leukemia
por: Chaudhary, Preety, et al.
Publicado: (2023)

PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
por: Chenbah, Wafa, et al.
Publicado: (2023)

Simultaneous Presentation of Hairy Cell Leukemia and Acute Lymphoblastic Leukemia
por: Li, Mingyong, et al.
Publicado: (2021)

2448 The effect of allopurinol on pediatric patients undergoing maintenance chemotherapy for acute lymphoblastic leukemia or lymphoblastic lymphoma
por: Bhuiyan, Mariam M., et al.
Publicado: (2018)

Genotype-Environment Interaction Analysis of NQO1, CYP2E1, and NAT2 Polymorphisms and the Risk of Childhood Acute Lymphoblastic Leukemia: A Report From the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia
por: Medina-Sanson, Aurora, et al.
Publicado: (2020)

B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrow
por: Barz, Malwine J., et al.
Publicado: (2022)

AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
por: Yu, M, et al.
Publicado: (2011)

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
por: Gervasini, Guillermo, et al.
Publicado: (2012)

Psychological Impact of Chemotherapy for Childhood Acute Lymphoblastic Leukemia on Patients and Their Parents
por: Sherief, Laila M., et al.
Publicado: (2015)

Encephalopathy and brain atrophy during induction chemotherapy in acute lymphoblastic leukemia
por: Li, Qiao‐Ru, et al.
Publicado: (2020)

Alterations in Bone Turnover during Chemotherapy in Children with Acute Lymphoblastic Leukemia
por: Gupta, Vineeta, et al.
Publicado: (2021)

The Effect of Chemotherapy Induction Therapy on the Pancreas in Patients with Acute Lymphoblastic Leukemia
por: Wondmeneh, Temesgen Gebeyehu, et al.
Publicado: (2022)

Oral manifestations resulting from chemotherapy in children with acute lymphoblastic leukemia
por: de Morais, Everton Freitas, et al.
Publicado: (2014)

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
por: Gibson, Amber, et al.
Publicado: (2021)

Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia
por: Boullosa, Laurie Freire, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_46cghebo2behjkjlhfoqk7bqv9